A Critical View of the Methods for Characterization of the VIP/PACAP Receptor Subclassesa
- 1 December 1998
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 865 (1 VIP, PAC) , 157-163
Abstract
The binding properties of the three cloned VIP/PACAP receptors and their coupling to G proteins and effectors can be studied in cells expressing each recombinant protein. The data obtained in these models must be critically evaluated:the expression of a high receptor density may reveal irrelevant receptors states and coupling to non-cognate G protein, and entail a marked amplification of the response as well as distortions in the selectivity profile of full and partial agonists. These models are, however, of great interest in the design of selective agonists and antagonists for each receptor subtype. The availability of selective ligands will facilitate the identification of the receptor subtype responsible for PACAP and VIP actions in cells and tissues.Keywords
This publication has 28 references indexed in Scilit:
- Effect of introduction of an Arginine16 in VIP, PACAP and secretin on ligand affinity for the receptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Cloning and Characterization of the Signal Transduction of Four Splice Variants of the Human Pituitary Adenylate Cyclase Activating Polypeptide ReceptorJournal of Biological Chemistry, 1996
- Differential alternative splicing of PACAP receptor in pituitary cell subpopulationsMolecular and Cellular Endocrinology, 1995
- Properties of Chimeric Secretin and VIP Receptor Proteins Indicate the Importance of the N-Terminal Domain for Ligand DiscriminationBiochemical and Biophysical Research Communications, 1995
- Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptorMolecular and Cellular Endocrinology, 1995
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Type I receptors for PACAP (a neuropeptide even more important than VIP?)Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Cloning of a Splice Variant of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Type I ReceptorBiochemical and Biophysical Research Communications, 1993
- Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogs with varying chain lengthsJournal of Medicinal Chemistry, 1986